Guide DNA — not RNA — expands the CRISPR toolkit - Nature

Biotechnology Breakthroughs That Are Changing Healthcare - Analytics Insight

Vir Biotechnology: Trading Near Cash Value With A Huge Revenue Opportunity (NASDAQ:VIR) - Seeking Alpha

MacroGenics sells manufacturing arm to Bora in $123m deal - The Pharma Letter

Sana Biotechnology Raises $69 Million Through Equity Offering - TipRanks

Sana Biotechnology (SANA) sells 21.6M shares to raise about $69M - Stock Titan

Puma Biotechnology Reveal Hidden Strength Amid Rising Market Focus - Kalkine Media

Sana Biotechnology Raises $69 Million Through ATM Equity Offering - marketscreener.com

Europe’s biotech dilemma: discovery at home, scale abroad - The Pharma Letter

Sana Biotechnology raises $69 million through stock sale By Investing.com - Investing.com Canada

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility - Yahoo Finance

There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings - simplywall.st

Biotechnology, hydroponics, and branding take center stage at Misiones floriculture event - FloralDaily

How Marianne De Backer saved Vir Biotechnology after flu drug failure - San Francisco Business Times - The Business Journals

Widespread DNA off-targeting confounds RNA chromatin occupancy studies - Nature